Union biometrics유니온바이오메트릭스
203450 · KOSDAQ · ₩203450 · 유니온바이오메트릭스
₩2,590▼ ₩30 (1.15%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩51B | ₩57B | ₩51B | ₩46B | ₩39B |
| Cost of sales | ₩32B | ₩37B | ₩34B | ₩31B | ₩25B |
| Gross profit | ₩19B | ₩20B | ₩18B | ₩16B | ₩14B |
| Operating income | ₩1B | ₩2.8B | ₩1.6B | ₩1.3B | ₩336M |
| Net income | ₩2B | ₩4.9B | ₩3.1B | ₩2.2B | ₩2.3B |
| Net income to shareholders | ₩2B | ₩4.9B | ₩3.1B | ₩2.2B | ₩2.4B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩63B | ₩71B | ₩60B | ₩56B | ₩56B |
| Current assets | ₩40B | ₩52B | ₩38B | ₩38B | ₩38B |
| Cash and equivalents | ₩7.6B | ₩22B | ₩11B | ₩5B | ₩11B |
| Total liabilities | ₩21B | ₩29B | ₩20B | ₩19B | ₩20B |
| Current liabilities | ₩14B | ₩23B | ₩15B | ₩14B | ₩15B |
| Borrowings | ₩8B | ₩8B | ₩8B | ₩8B | ₩9B |
| Total equity | ₩41B | ₩42B | ₩40B | ₩37B | ₩36B |
| Shareholders' equity | ₩41B | ₩42B | ₩40B | ₩37B | ₩36B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩12B | ₩11B | ₩9.8B | −₩2.1B | ₩1.1B |
| Capital spending | ₩633M | ₩702M | ₩515M | ₩546M | ₩317M |
| Free cash flow | −₩13B | ₩11B | ₩9.3B | −₩2.7B | ₩814M |
| Dividends paid | ₩858M | ₩899M | ₩21M | ₩0 | ₩932M |
Consolidated where available. Amounts in won.
Also known as: Union biometrics / 유니온바이오메트릭스 / 203450 / KRX:203450
Source: KRX statistical information